The Association between Leucocyte Telomere Length and Survival Outcomes in Patients with Cardiovascular Disease

Jin-Yu Sun1,2, Qian Xu2, Hui Shen2

  • 1Department of Cardiology, Gusu School, Nanjing Medical University, 215008 Suzhou, Jiangsu, China.

PubMed

Insights

Shorter leucocyte telomere length (LTL) is linked to increased all-cause mortality in cardiovascular disease (CVD) patients, particularly women. This finding highlights LTL as a potential marker for CVD tertiary prevention.

Area of Science:

  • Biomedical research
  • Cardiovascular epidemiology
  • Gerontology

Background:

  • Investigating the relationship between leucocyte telomere length (LTL) and mortality risk in patients with cardiovascular disease (CVD).
  • Understanding the role of cellular aging markers in predicting adverse outcomes in CVD populations.

Purpose of the Study:

  • To explore the association between LTL and all-cause mortality.
  • To assess the impact of LTL on cardiovascular disease (CVD)-specific death.

Main Methods:

  • Utilized data from 1599 CVD patients from a US population survey.
  • Employed Kaplan-Meier curves, weighted Cox regression, and restricted cubic splines for all-cause mortality analysis.
  • Applied competing risk regression to evaluate CVD-specific mortality, with non-CVD death as a competing event.

Main Results:

  • Shorter LTL was associated with a higher risk of all-cause death (adjusted HR: 1.25).
  • A linear dose-response relationship was observed between LTL and all-cause mortality.
  • Female patients with shorter LTL showed a significantly higher risk of death (weighted HR: 1.79), unlike males.
  • No significant association was found between LTL and CVD-specific mortality, but a significant link to non-CVD death (adjusted HR: 1.24).

Conclusions:

  • Leucocyte telomere length (LTL) is inversely associated with all-cause mortality in female CVD patients.
  • Reduced LTL may serve as a prognostic indicator for increased all-cause mortality in CVD patients.
  • LTL emerges as a potential biomarker for tertiary prevention strategies in cardiovascular disease.
Abstract

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
104
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
101
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
188
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
26